(Q36198661)

12 August 2017

1 reference

title

Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens (English)

1 reference

12 August 2017

Maxim Pavlenko

1

1 reference

12 August 2017

Christoph Leder

series ordinal

2

1 reference

12 August 2017

Pavel Pisa

series ordinal

3

1 reference

12 August 2017

publication date

1 June 2005

1 reference

Expert Review of Vaccines

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

315-327

1 reference

Direct gene transfer into mouse muscle in vivo

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

MHC class II restricted antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

MHC class I-restricted CTL responses to exogenous antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Augmentation of DNA vaccine potency through secretory heat shock protein-mediated antigen targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Targeting plasmid-encoded proteins to the antigen presentation pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Pervasive CpG suppression in animal mitochondrial genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Mini-review CD4 T cells are required for CD8 T cell memory generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Cervical cancer vaccines: recent advances in HPV research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

T cell-based therapies for EBV-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

CD4 and CD8 T-lymphocyte recognition of prostate specific antigen in granulomatous prostatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Cytotoxic T cells isolated from ovarian malignant ascites recognize a peptide derived from the HER-2/neu proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Tumor immunity and autoimmunity induced by immunization with homologous DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Immunization with DNA coding for gp100 results in CD4 T-cell independent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

DNA vaccines: an active immunization strategy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

High-efficiency gene transfer into skeletal muscle mediated by electric pulses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Intralymphatic immunization enhances DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

DNA vaccines to attack cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Use of CpG oligodeoxynucleotides as immune adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Cytokines and costimulatory molecules as genetic adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Immunity against solid tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Prime boost vaccines power up in people

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Particle-mediated DNA vaccine delivery to the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Microparticles for the delivery of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

CpG motifs are efficient adjuvants for DNA cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

CTL Response and Protection Against P815 Tumor Challenge in Mice Immunized with DNA Expressing the Tumor-Specific Antigen P815A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.3.315

21 January 2018

Identifiers

DOI

10.1586/14760584.4.3.315

1 reference

12 August 2017

1 reference